scholarly journals General movement assessment is correlated with neonatal behavior neurological assessment/cerebral magnetic resonance imaging in preterm infants

Medicine ◽  
2021 ◽  
Vol 100 (37) ◽  
pp. e27262
Author(s):  
Jinjun Zhou ◽  
Shuangshuang Li ◽  
Li Gu ◽  
Xiaohua Zhang ◽  
Zhen Tang
1997 ◽  
Vol 42 (3) ◽  
pp. 391-391
Author(s):  
Malcolm Battin ◽  
Elia Maalouf ◽  
Mary Rutherford ◽  
Serena Counsell ◽  
Amy Herlihy ◽  
...  

2021 ◽  
Vol 18 (3) ◽  
pp. 39-43
Author(s):  
Suraj Thulung ◽  
Nikunj Yogi

Introduction: Incidence of diffuse axonal injury has been estimated at 40-50% of hospitalizations. Recently, much interest has been directed towards the potential of newer imaging sequences of magnetic resonance imaging to investigate diffuse axonal injury (DAI) and to prognosticate the outcome. In this study, we correlated the magnetic resonance imaging grades of diffuse axonal injury with clinical outcome in terms of Glasgow Outcome Scale (GOS). Methods and Materials: A hospital based observational study was carried out at Upendra Devkota Memorial National Institute of Neurological and Allied Sciences, Kathmandu in 69 patients of diffuse axonal injury between November 2017 to November 2018. Data was collected on patient and trauma characteristics, as well as neurological assessment and MRI findings. Outcome was assessed as favourable and unfavourable GOS for various MRI grades of diffuse axonal injury. Results: There were 21.74%, 42.03% and 36.23% of cases with grade I, II and III diffuse axonal injury respectively. There were 0 (0%), 2 (11.8%) and 15 (88.2%) cases of MRI grade I, II and III diffuse axonal injury in favourable GOS group and 15 (28.8%), 27 (51.9%) and 10 (19.2%) cases of MRI grade I, II and III diffuse axonal injury in unfavourable GOS group (p=0.00). Conclusion: This study showed that there was a significantly higher chance of unfavourable outcome with increasing MRI grades of diffuse axonal injury.


NeoReviews ◽  
2013 ◽  
Vol 14 (10) ◽  
pp. e490-e500 ◽  
Author(s):  
Cynthia M. Ortinau ◽  
Terrie E. Inder ◽  
Christopher D. Smyser

2012 ◽  
Vol 5 (4) ◽  
pp. 363-371 ◽  
Author(s):  
C. Petropoulou ◽  
H. Bouza ◽  
I. Nikas ◽  
G. Chrousos ◽  
M. Anagnostakou ◽  
...  

2015 ◽  
Vol 7 (1) ◽  
Author(s):  
Manjinder Kaur ◽  
Emily S. Nia ◽  
Rebecca A. Millius ◽  
Dominick G. Sudano ◽  
Jeffrey R. Lisse

Neuro-Behçet’s disease (NBD) is a rare but severe manifestation of Behçet’s disease. Patients with NBD tend to have high morbidity and mortality. Some patients do not respond adequately to conventional therapy (corticosteroids and immunosuppressants). This has led to treatment gaps in the therapy of NBD. There are reports in the literature of patients with Behçet’s disease responding to anti-TNF therapy. We present a case of a male patient with biopsy proven cerebral vasculitis presenting as NBD who has been in remission with near resolution of cerebral magnetic resonance imaging lesions for 4 years following treatment with infliximab and azathioprine.


Sign in / Sign up

Export Citation Format

Share Document